An Open Label, Single Dose, Dose-escalating Phase I/IIa Study to Determine the Safety and Clinical Effects of Intra-articular Injections of Lopain (MTX-071) in Patients With Chronic Osteoarthritic Knee Joint Pain
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2016
At a glance
- Drugs MTX 071 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 20 Sep 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2016.
- 20 Sep 2016 Status changed from not yet recruiting to recruiting.
- 09 Oct 2015 New trial record